14.09.2022 • NewsLyondellBasellolefinsresins

LyondellBasell Wins Two Lupotech PE Projects

LyondellBasell has won two separate contracts to supply its Lupotech T high-pressure technology for new PE plants.

© LyondellBasell
© LyondellBasell

One award is from South Korea’s Hanwha Solutions, which is planning a 300,000 t/y PE and ethylene vinyl acetate copolymer (EVA) plant in Yeosu.

“Hanwha is an experienced producer of LDPE and EVA resins in South Korea and we are excited that Hanwha opted for the Lupotech T process to expand their production capacity with this significant award,” said Neil Nadalin, director global licensing and services at LyondellBasell.

The second contract was from PKN Orlen in Poland, which will install a 250,000 t/y LDPE plant at its existing site in Plock.

“Once the plant is started-up, PKN Orlen will expand its product portfolio with benchmark LDPE resins. The program to expand the value chain of olefins, especially ethylene and downstream products, is in line with PKN Orlen’s strategy,” said Daniel Obajtek, PKN Orlen’s president, adding that the LDPE project is the foundation for further development, also contributing to an increase in petrochemicals’ share of the group’s EBITDA.

A start-up date for both projects was not disclosed.

Auhtor: Elaine Burridge, Freelance Journalist

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.